IPOs
After Pershing Square Holdings losses at Valeant Pharmaceuticals $4 billion, Bill Ackman said he will probably stay away from pharmaceutical companies.
Hi, what are you looking for?
After Pershing Square Holdings losses at Valeant Pharmaceuticals $4 billion, Bill Ackman said he will probably stay away from pharmaceutical companies.
Teddy Sagi's privately held LabTech Investments buy the 29% of Market Tech it does not already own; valuing Market Tech at $1.14 billion.
Israel’s €2.25 billion 10 & 20 year government bonds start trading on London Stock Exchange today
– The regulator’s decision to declare Tamar and Leviathan a monopoly could hit Delek’s planned London IPO. – /Amiram Barkat and Ron Stein/ Delek...
– Delek CEO: A London listing will help us become a leading international energy company. – In its third quarter financial report published...
In June, Bidvest CEO Brian Joffe discussed the possibility of listing the company’s food service business on the London Stock Exchange while the market...
Tireless activist investor Bill Ackman of Pershing Square Capital Management announced that he is proposing an initial public offering on the London Stock Exchange...
Delek is considering a dual listing on the London Stock Exchange in addition to its listing in Tel Aviv. The company was also mulling...
Israeli company Crossrider, a provider of digital marketing and advertising services, is planning to go public on the London Stock Exchange. Scheduled for September,...
Bill Ackman is reportedly making plans to raise $4 billion for a close-end fund on the London Stock Exchange, following the lead of...